Phase II Study on Sitagliptin -Assessment of Glucose-lowering Effects
Phase II Study on Sitagliptin -Assessment of Glucose-lowering Effects
A clinical study determines the safety and efficacy of sitagliptin (MK0431) in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Inclusion Criteria:
Exclusion Criteria: